Safety of celecoxib and nonselective nonsteroidal anti-inflammatory drugs in juvenile idiopathic arthritis: results of the Phase 4 registry

This study aimed to assess long-term safety and developmental data on juvenile idiopathic arthritis (JIA) patients treated in routine clinical practice with celecoxib or nonselective nonsteroidal anti-inflammatory drugs (nsNSAIDs). Children aged ≥2 to

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pediatric Rheumatology 2014-07, Vol.12 (1), p.29-29, Article 29
Hauptverfasser:	Sobel, Rachel E, Lovell, Daniel J, Brunner, Hermine I, Weiss, Jennifer E, Morris, Paula W, Gottlieb, Beth S, Chalom, Elizabeth C, Jung, Lawrence K, Onel, Karen B, Petiniot, Lisa, Goldsmith, Donald P, Nanda, Kabita, Shishov, Michael, Abramsky, Staci, Young, James P, Giannini, Edward H
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Anti-Inflammatory Agents, Non-Steroidal - administration & dosage Anti-Inflammatory Agents, Non-Steroidal - adverse effects Anti-Inflammatory Agents, Non-Steroidal - classification Arthritis, Juvenile - drug therapy Celecoxib Child Child, Preschool Children & youth Dosage and administration Drug therapy Drug-Related Side Effects and Adverse Reactions - diagnosis Drug-Related Side Effects and Adverse Reactions - epidemiology Drug-Related Side Effects and Adverse Reactions - etiology Female Hospitals Humans Male Medication Therapy Management Nonsteroidal anti-inflammatory drugs Patient Safety Pharmaceutical industry Product development Pyrazoles - administration & dosage Pyrazoles - adverse effects Registries Safety and security measures Sulfonamides - administration & dosage Sulfonamides - adverse effects Time United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This study aimed to assess long-term safety and developmental data on juvenile idiopathic arthritis (JIA) patients treated in routine clinical practice with celecoxib or nonselective nonsteroidal anti-inflammatory drugs (nsNSAIDs). Children aged ≥2 to
ISSN:	1546-0096 1546-0096
DOI:	10.1186/1546-0096-12-29